Lonza | LONN - Nettoeinkommen

Aktienkurs
490.15
Täglich Wechseln
2.15 0.44%
Monatlich
-4.08%
Jährlich
-13.19%
Q2 Prognose
460.06




Nettoeinkommen Veränderung Datum
Akzo Nobel EUR 93M 505M 2026-03
Alcon AG USD 189M 28M 2026-03
Almirall EUR 19.58M 7M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
BASF EUR 927M 367M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Beiersdorf EUR 387M 165M 2025-12
Covestro EUR -378M 331M 2025-12
Demant DKK 427M 690M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 118M 209M 2026-03
Geberit CHF 103.5M 52.3M 2025-12
Genmab DKK 31M 370M 2025-12
Givaudan CHF 479M 113M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GN Store Nord DKK -955M 1.3B 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Johnson Matthey GBP -18M 93M 2025-12
Merck EUR 659M 340M 2026-03
Novartis USD 3.16B 747M 2026-03
Philips EUR 151M 244M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Sika AG CHF 490.2M 63.6M 2025-12
Smith & Nephew USD 293M 79M 2025-12
Solvay EUR 26M 121M 2026-03
UCB EUR 1.08B 608M 2025-12